GRK3 and prostate carcinoma: In neuroendocrine prostate cancer, the CREB/G-protein-coupled receptor kinase (GRK) 3 axis promotes neuroendocrine differentiation of the prostate cancer cells, whereas CREB activation is mediated by GRK3.